Pemphigus associated with ipilimumab therapy
Int J Dermatol
.
2021 Aug;60(8):e331-e333.
doi: 10.1111/ijd.15405.
Epub 2021 Jan 7.
Authors
Elizabeth Schoenberg
1
,
Beth Colombe
2
,
Jisun Cha
3
,
Marlana Orloff
4
,
Doaa Shalabi
5
,
Nicholas A Ross
3
,
Bahar Dasgeb
3
4
Affiliations
1
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
2
Histocompatibility and Tissue Typing Laboratory, Thomas Jefferson University, Philadelphia, PA, USA.
3
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA.
4
Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
5
SUNY Downstate Health Sciences University College of Medicine, Brooklyn, NY, USA.
PMID:
33410503
DOI:
10.1111/ijd.15405
No abstract available
Publication types
Letter
MeSH terms
Humans
Ipilimumab / adverse effects
Melanoma* / drug therapy
Nivolumab
Pemphigus* / chemically induced
Pemphigus* / drug therapy
Substances
Ipilimumab
Nivolumab